Harris Goldstein Selected Research

Harris Goldstein Research Topics

Disease

26	Infections 02/2024 - 08/2002
12	HIV Infections (HIV Infection) 05/2024 - 09/2002
7	Acquired Immunodeficiency Syndrome (AIDS) 10/2019 - 10/2004
5	Viremia 01/2024 - 02/2005
4	Neoplasms (Cancer) 05/2024 - 03/2008
3	Virus Diseases (Viral Diseases) 01/2024 - 08/2002
2	Disease Progression 10/2017 - 02/2014
2	Encephalitis (Encephalitis, Rasmussen) 01/2006 - 08/2002
2	Dementia (Dementias) 01/2006 - 10/2004
1	Leukemia 05/2024
1	Inflammation (Inflammations) 01/2024
1	Syphilis 01/2022
1	Gonorrhea 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Coinfection 09/2015
1	Neurocognitive Disorders (Clerambault Syndrome) 11/2010
1	Persistent Infection 05/2007
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2006

Drug/Important Bio-Agent (IBA)

4	Antiviral Agents (Antivirals)IBA 05/2024 - 05/2007
4	Broadly Neutralizing AntibodiesIBA 10/2019 - 10/2017
4	Cyclin TIBA 01/2016 - 11/2009
3	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2019
3	AntibodiesIBA 12/2018 - 07/2010
3	LuciferasesIBA 01/2016 - 01/2013
2	AntigensIBA 01/2024 - 03/2008
2	Tenofovir (Viread)FDA Link 01/2022 - 09/2015
2	EpitopesIBA 10/2019 - 06/2007
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 11/2010
2	nanolucIBA 01/2016 - 09/2015
2	Anti-Infective Agents (Microbicides)IBA 09/2015 - 01/2008
2	RNA (Ribonucleic Acid)IBA 02/2014 - 07/2010
2	VaccinesIBA 01/2009 - 01/2008
2	Chemokine CCL5IBA 09/2002 - 08/2002
1	LigandsIBA 05/2024
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Emtricitabine (Emtriva)FDA Link 01/2022
1	Therapeutic UsesIBA 10/2019
1	Peptides (Polypeptides)IBA 01/2017
1	4Dm2mIBA 05/2016
1	ProdrugsIBA 09/2015
1	Interleukin-15 (Interleukin 15)IBA 06/2015
1	CD4 Antigens (CD4 Antigen)IBA 02/2015
1	Glycoproteins (Glycoprotein)IBA 02/2015
1	Human immunodeficiency virus 1 p16 proteaseIBA 04/2012
1	Insulin-Like PeptidesIBA 11/2010
1	Immunoglobulin M (IgM)IBA 07/2010
1	Immunoglobulin G (IgG)IBA 07/2010
1	HIV AntibodiesIBA 07/2010
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2009
1	LipopolysaccharidesIBA 08/2008
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2008
1	Monoclonal AntibodiesIBA 11/2006
1	Tight Junction ProteinsIBA 01/2006
1	ChemokinesIBA 01/2006
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006
1	Minocycline (Cyclops)FDA LinkGeneric 10/2004
1	CC ChemokinesIBA 09/2002
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 08/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2002
1	Macrophage Colony-Stimulating FactorIBA 08/2002

Therapy/Procedure

10	Therapeutics 01/2024 - 10/2004
4	Art Therapy 02/2024 - 01/2019
3	Highly Active Antiretroviral Therapy (HAART) 07/2010 - 11/2002
2	Intravenous Injections 01/2016 - 01/2013
2	Transplantation 07/2010 - 07/2010
1	Hematopoietic Stem Cell Transplantation 05/2024
1	Condoms (Condom) 01/2022
1	Drug Therapy (Chemotherapy) 01/2019
1	Intraperitoneal Injections 07/2010